Trademark: RELIZORB
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for RELIZORB
We do not have any records of a proof of use for RELIZORB at this moment.
Possible trademark infringements of RELIZORB
Basic Information about RELIZORB
- Serial Number
- 86690981
- Filing Date
- 13 Jul 2015
- Registration Number
- 5087672
- Registration Date
- 22 Nov 2016
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of RELIZORB on the blockchain with WikiTrademarks.io.
- First use of RELIZORB anywhere
- RELIZORB was first used on 24 Nov 2015 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
- First use of RELIZORB anywhere
- RELIZORB was first used on 24 Nov 2015 for the primary classification of goods and services, international, 010 (Medical Apparatus)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 010
- US Codes
- 026; 039; 044
Who owns RELIZORB?
1. ALCRESTA THERAPEUTICS, INC. Waltham MA
2. ALCRESTA THERAPEUTICS, INC. NEWTON MA
3. Alcresta, Inc. Newton MA
4. Alcresta, Inc. Newton MA
Correspondent
- Perry J. Viscounty, Esq.
- Latham & Watkins LLP
- 650 Town Center Drive, Suite 2000
- Costa Mesa,CA 92626
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io